MétaCan
Menu
Back to cohort
Record W4323353562 · doi:10.1093/brain/awad072

Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study

2023· article· en· W4323353562 on OpenAlexafffund
Stephen Joza, Ki‐Young Jung, Dieter Kunz, Ambra Stefani, Petr Dušek, Michele Terzaghi, Dario Arnaldi, Aleksandar Videnović, Mya C. Schiess, Wiebke Hermann, Jee‐Young Lee, Luigi Ferini‐Strambi, Simon J.G. Lewis, Laurène Leclair‐Visonneau, Wolfgang H. Oertel, Elena Antelmi, Friederike Sixel‐Döring, Valérie Cochen De Cock, Claudio Liguori, Jun Liu, Federica Provini, Monica Puligheddu, Alessandra Nicoletti, Claudio L. Bassetti, Jitka Bušková, Yves Dauvilliers, Raffaele Ferri, Jacques Montplaisir, Michael Lawton, Han‐Joon Kim, Frédérik Bes, Birgit Högl, Karel Šonka, Giuseppe Fiamingo, Pietro Mattioli, Maria L. Lavadia, Jessika Suescun, Kyung Ah Woo, Sara Marelli, Kaylena A. Ehgoetz Martens, Annette Janzen, Giuseppe Plazzi, Brit Mollenhauer, Mariana Fernandes, Yuanyuan Li, Pietro Cortelli, Michela Figorilli, Calogero Edoardo Cicero, Carolin Schaefer, Lily Guiraud, Giuseppe Lanza, Jean‐François Gagnon, Jun‐Sang Sunwoo, Abubaker Ibrahim, Nicola Girtler, Claudia Trenkwalder, Luca Baldelli, Amélie Pelletier, Ronald B. Postuma

Bibliographic record

VenueBrain · 2023
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsUniversity of WaterlooHôpital du Sacré-Cœur de MontréalUniversité du Québec à MontréalCanadian Sleep & Circadian NetworkMontreal Neurological Institute and Hospital
FundersNational Research Foundation of KoreaEdmond J. Safra Center for Ethics, Harvard UniversityMinistry of Science, ICT and Future PlanningNational Research FoundationParkinsonFonds DeutschlandParkinson's UKCanadian Institutes of Health ResearchNational Institute for Health and Care ResearchMichael J. Fox Foundation for Parkinson's Research
KeywordsDementia with Lewy bodiesREM sleep behavior disorderDementiaProdromal StageCognitive declineParkinson's diseasePsychologyLewy bodySubclinical infectionDiseaseInternal medicineMedicinePsychiatry

Abstract

fetched live from OpenAlex

The neurodegenerative synucleinopathies, including Parkinson's disease and dementia with Lewy bodies, are characterized by a typically lengthy prodromal period of progressive subclinical motor and non-motor manifestations. Among these, idiopathic REM sleep behaviour disorder is a powerful early predictor of eventual phenoconversion, and therefore represents a critical opportunity to intervene with neuroprotective therapy. To inform the design of randomized trials, it is essential to study the natural progression of clinical markers during the prodromal stages of disease in order to establish optimal clinical end points. In this study, we combined prospective follow-up data from 28 centres of the International REM Sleep Behavior Disorder Study Group representing 12 countries. Polysomnogram-confirmed REM sleep behaviour disorder subjects were assessed for prodromal Parkinson's disease using the Movement Disorder Society criteria and underwent periodic structured sleep, motor, cognitive, autonomic and olfactory testing. We used linear mixed-effect modelling to estimate annual rates of clinical marker progression stratified by disease subtype, including prodromal Parkinson's disease and prodromal dementia with Lewy bodies. In addition, we calculated sample size requirements to demonstrate slowing of progression under different anticipated treatment effects. Overall, 1160 subjects were followed over an average of 3.3 ± 2.2 years. Among clinical variables assessed continuously, motor variables tended to progress faster and required the lowest sample sizes, ranging from 151 to 560 per group (at 50% drug efficacy and 2-year follow-up). By contrast, cognitive, olfactory and autonomic variables showed modest progression with higher variability, resulting in high sample sizes. The most efficient design was a time-to-event analysis using combined milestones of motor and cognitive decline, estimating 117 per group at 50% drug efficacy and 2-year trial duration. Finally, while phenoconverters showed overall greater progression than non-converters in motor, olfactory, cognitive and certain autonomic markers, the only robust difference in progression between Parkinson's disease and dementia with Lewy bodies phenoconverters was in cognitive testing. This large multicentre study demonstrates the evolution of motor and non-motor manifestations in prodromal synucleinopathy. These findings provide optimized clinical end points and sample size estimates to inform future neuroprotective trials.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.020
Threshold uncertainty score0.417

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.356
Teacher spread0.323 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations124
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueBrainSame topicParkinson's Disease Mechanisms and TreatmentsFrench-language works237,207